However, regardless of MIF overexpression and HIF-1α activation, the glucose metabolism index levels of AT2 cells after treatment were still significantly lower than those of H1703 and Calu-3 lung cancer cell lines (Supplementary Figure 3A-C). The gene discussed is MIF; the disease is lung carcinoma.